Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
B. Segura-Collar, J. Jimenez-Sanchez, R. Gargini…·V. M. Perez-Garcia
This study uses in-silico models and experimental data to show that longer TMZ dose intervals improve survival and reduce toxicity in slowly growing gliomas by altering tumor phenotype.
B. Segura-Collar, M. Garranzo-Asensio, B. Herranz…·P. Sanchez-Gomez
This study investigates how IDH1/2 and EGFR genetic mutations influence vascular characteristics and progression in gliomas, identifying distinct vascular phenotypes and therapeutic vulnerabilities.
P. Sanchez-Gomez, J. M. Sepulveda-Sanchez, T. Cejalvo…·M. C. Martin-Soberon
The paper profiles immune cells in gliomas, identifying two immune profiles in IDH1/2 wild-type tumors and linking immune content to vascular alterations and Tau expression.
R. Gargini, B. Segura-Collar, V. Garcia-Escudero…·A. Perez-Nunez
This study identifies the IDH-Tau-EGFR triad as a key factor in defining the neovascular landscape of diffuse gliomas by regulating mesenchymal differentiation and vascular microenvironment.